BioTech Mag Search: Therapeutics
Phase I study of opaganib, an oral sphingosine kinase 2-specific inhibitor, in relapsed and/or refractory multiple myeloma
1 month ago - By Springer
Abstract
Multiple myeloma remains an incurable disease and there is an unmet medical need for novel therapeutic drugs that do not share similar mechanisms of action with currently available agents. Sphingosine kinase 2 is an innovative molecular target for anticancer therapy. We previously reported that treatment with SK2 inhibitor opaganib inhibited myeloma tumor growth in vitro and in vivo in a mouse xenograft model. In the current study, we performed a phase I study of opaganib in patients with relapsed/refractory multiple myeloma. Thirteen patients with RRMM previously treated with...
Read more ...
Search by Tags
Therapeutics Drug Drugs Therapies
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Nf-core/circrna: a portable workflow for the quantification, miRNA target...
Circular RNAs are a class of covalenty closed non-coding RNAs that have garnered increased attention from the research community due to their stability, tissue-specific...
Effective matrix designs for COVID-19 group testing
Grouping samples with low prevalence of positives into pools and testing these pools can achieve considerable savings in testing resources compared with individual testing in...
New methods to improve super-resolution imaging techniques give a sharper...
New methods to improve super-resolution imaging techniques are giving biologists a clearer and more complete view of the inner workings of living cells.
AIHM declares January Integrative Health Month!
SAN DIEGO, Jan. 26, 2023 /PRNewswire/ - The Academy of Integrative Health officially declares January as Integrative Health Month. AIHM represents 50+ organizations of tens of...
COVID Virus Ventures Beyond the Lungs, Often Lodging in the Brain
In early 2020, COVID appeared to be mostly respiratory, with blame for the shattering of delicate lung tissues initially placed on the violent “cytokine storms” unleashed from...
Lost Video of Georges Lemaître, Father of the Big Bang Theory, Recovered
Companies Already Have the Ability to Decode Your Brainwaves
It wasn't like Duke University futurist Nita Farahany wanted to bring nonstop doom and gloom during her recent “The Battle for Your Brain” presentation at last week's World...
Phosphorothioated amino-AS1411 aptamer functionalized stealth nanoliposome...
Hepatocellular carcinoma is a leading cause of death globally. Even though the progressive invention of some very potent therapeutics has been seen, the success is limited due...
Magnetofection of miR-21 promoted by electromagnetic field and iron oxide...
Magnetofection-mediated gene delivery shows great therapeutic potential through the regulation of the direction and degree of differentiation. Lumbar degenerative disc disease...
Tumor-penetrating nanoplatform with ultrasound “unlocking” for cascade...
Combined therapy based on the effects of cascade reactions of nanoplatforms to combat specific solid tumor microenvironments is considered a cancer treatment strategy with...